IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1599 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Etizolam withdrawal catatonia: The first case report
Debanjan Banerjee
Asian Journal of Psychiatry.2018;37()32
2An expanding world of new psychoactive substances—designer benzodiazepines
Jolanta B. Zawilska,Jakub Wojcieszak
3Les « designer benzodiazepines » : qu’en sait-on aujourd’hui ?
Emil Chetraru,Alice Ameline,Laurie Gheddar,Jean-Sébastien Raul,Pascal Kintz
Toxicologie Analytique et Clinique.2018;30(1)5
4Etizolam: A rapid review on pharmacology, non-medical use and harms
Suzanne Nielsen,Andrew McAuley
Drug and Alcohol Review.2020;39(4)330
5Novel Ways to Acquire Designer Benzodiazepines: A Case Report and Discussion of the Changing Role of the Internet
Anna P. Shapiro,Travis S. Krew,Mohsen Vazirian,Jason Jerry,Christopher Sola
6Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance
Francesco Paolo Busardò,Annagiulia Di Trana,Eva Montanari,Simona Mauloni,Adriano Tagliabracci,Raffaele Giorgetti
Forensic Science International.2019;301(6)137
7Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine
Sabrina Lehmann,Alissa Sczyslo,Judith Froch-Cortis,Markus Alexander Rothschild,Mario Thevis,Hilke Andresen-Streichert,Katja Mercer-Chalmers-Bender
Forensic Science International.2019;303(6)109959
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow